Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New therapeutic agents for gastrointestinal disorders reported in recent patent literature

Dec. 21, 2006

Tysabri sBLA filed for Crohn's disease

Dec. 19, 2006

JKB-122 set for phase II study for liver function restoration in hepatitis C patients

Dec. 18, 2006

European labeling agreement for Mezavant

Dec. 18, 2006

Schering-Plough to acquire rights to pradefovir

Dec. 18, 2006

Abbott and Enanta partner on HCV protease inhibitors

Dec. 18, 2006

Interim safety analysis findings from phase IIb telaprevir HCV study

Dec. 15, 2006

New agents for gastrointestinal disorders reported in recent patents

Dec. 15, 2006

Novel therapeutic agents for hepatitis C virus infection disclosed in recent patent literature

Dec. 14, 2006

Intercell completes phase II trial for therapeutic hepatitis C vaccine IC-41

Dec. 14, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026